Acro Biomedical (ACBM) Accumulated Expenses (2021 - 2022)
Acro Biomedical's quarterly Accumulated Expenses came in at $19.8 million in Q1 2022, down 16.52% quarter-over-quarter from $23.8 million in Q4 2021.
Acro Biomedical has reported Accumulated Expenses for 2 years, with the latest figure at $19.8 million in Q1 2022.
- For the quarter ending Q1 2022, Accumulated Expenses changed N/A year-over-year to $19.8 million; the trailing twelve-month figure through Mar 2022 stood at $19.8 million (changed N/A YoY), and the FY2021 full-year result was $23.8 million, changed N/A from the prior year.
- Accumulated Expenses for Q1 2022 stood at $19.8 million, down from $23.8 million in the prior quarter.
- The five-year high for Accumulated Expenses was $23.8 million in Q4 2021, with the low at $18.5 million in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 19.85 Mn |
| Dec 31, 2021 | 23.77 Mn |
| Jun 30, 2021 | 18.51 Mn |